ArticleCureus2025
A Case of Primary Malignant Mixed Mesonephric Tumor of the Vagina.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mesonephric adenocarcinoma is a clinically aggressive, rare malignant neoplasm characterized by mesonephric (Wolffian) differentiation. It can occur throughout the female genital tract; however, most cases arise in the uterine cervix. Vaginal mesonephric adenocarcinoma is uncommon, and cases with a concomitant sarcomatous component are extremely rare. Using appropriate immunohistochemistry, we present a rare case of a primary malignant mixed mesonephric tumor of the vagina, defined by biphasic epithelial and mesenchymal malignant components of mesonephric origin. The patient was a 34-year-old woman who presented with vaginal pain and bleeding. Pelvic examination and diagnostic imaging revealed a primary vaginal tumor measuring approximately 4 cm without distant metastases. Histological examination of the biopsy specimen revealed an adenocarcinoma with a sarcomatous component. Our initial diagnosis was primary vaginal carcinosarcoma; however, additional immunohistochemistry of the tumor revealed luminal membranous positivity for CD10, diffuse nuclear staining for TTF1, and estrogen receptor negativity. These findings led to a final diagnosis of a primary malignant mixed mesonephric tumor of the vagina. Because of the patient's young age and desire for fertility preservation, curative concurrent chemoradiation was performed after oocyte and ovarian cryopreservation and migration via laparoscopic surgery. The tumor showed a marked reduction in size within three months and remained under control. This case emphasizes the need for clinicians and pathologists to consider the possibility of a mesonephric origin when encountering vaginal adenocarcinoma with a sarcomatous component. Appropriate immunohistochemical analysis is essential for establishing an accurate diagnosis and developing effective therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.